Related references
Note: Only part of the references are listed.Volume-Based Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Improve Outcome Prediction in Early-Stage Non-Small Cell Lung Cancer After Surgical Resection
Seung Hyup Hyun et al.
ANNALS OF SURGERY (2013)
Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy
Yoko Satoh et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy
Jonathan A. Abelson et al.
LUNG CANCER (2012)
Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer
Keunyoung Kim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
Joe Y. Chang et al.
RADIATION ONCOLOGY (2012)
Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?
Katy Clarke et al.
RADIOTHERAPY AND ONCOLOGY (2012)
MAXIMUM STANDARDIZED UPTAKE VALUE FROM STAGING FDG-PET/CT DOES NOT PREDICT TREATMENT OUTCOME FOR EARLY-STAGE NON SMALL-CELL LUNG CANCER TREATED WITH STEREOTACTIC BODY RADIOTHERAPY
Michael J. Burdick et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project
Marianne Paesmans et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer
Man Ki Chung et al.
CLINICAL CANCER RESEARCH (2009)
METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER
Trang H. La et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Primary Non–Small Cell Lung Cancer: Review of Frequency, Location, and Time of Recurrence after Radiofrequency Ablation
Michael D. Beland et al.
RADIOLOGY (2009)
Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma
Matthew R. Vernon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Metabolic tumor burden predicts for disease progression and death in lung cancer
Percy Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
The IASLC lung cancer staging project:: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer
Ramon Rami-Porta et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study
Hiroshi Onishi et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
David J. Hoopes et al.
LUNG CANCER (2007)
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma - Clinical outcomes in 245 subjects in a Japanese multinstitutional study
H Onishi et al.
CANCER (2004)
A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices
H Onishi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Share Paper
